Esaote North America awarded MRI Ancillary Equipment and Coils agreement with Premier, Inc.
Comunicato Precedente
Comunicato Successivo
"Compared to conventional scanners, the O-scan has a compact footprint that can fit into almost any clinical setting and a comfortable, open-concept design that is ideal for scanning children and claustrophobic patients," says Stephen Gibbs, Marketing and Sales Manager at Esaote North America, Inc.
"The O-scan is a high-impact, low-power consumption solution, poised to take on complex workflow challenges without compromising image quality or productivity," says Robert Lewis, President and General Manager at Esaote North America, Inc.
Esaote is internationally recognized for its Dedicated MRI systems, ultrasound point-of-care, and Healthcare IT workflow solutions. Esaote's founding philosophies continue to push the technological boundaries of the medical device industry, delivering cost-effective and eco-friendly diagnostic imaging solutions to meet customer demands worldwide.
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,400 U.S. hospitals and 250,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting, and other services, Premier enables better care and outcomes at a lower cost.
About Esaote
Esaote North America, Inc. is part of the Esaote Group, a leader in the biomedical equipment sector, especially ultrasound, MRI, and medical Healthcare IT. With 1,250 employees, facilities in Genoa and Florence, and production and research units in Italy and the Netherlands, the Company is present in over 100 countries worldwide. www.esaote.com.
Photo - https://mma.prnewswire.com/media/2104063/Esaote_O_scan_Premium.jpg
Logo - https://mma.prnewswire.com/media/1421470/Esaote_North_America_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/esaote-north-america-awarded-mri-ancillary-equipment-and-coils-agreement-with-premier-inc-301853299.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
